• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

U.S. Federal Trade Commission

Martin Shkreli
Pharma

FTC alleges Martin Shkreli violated pharma ban with stock trades

The FTC alleges that Shkreli publicly traded pharma stocks and encouraged his followers to short certain stocks.
Donavyn Coffey Oct 14, 2026 8:40am
Congress senate house government US

Bipartisan bill targets foreign drugmaking in US

Jul 16, 2026 11:27am
Sign on doorway for FTC in Washington DC

Aurobindo must divest 4 drugs to complete Lannett buyout: FTC

Jun 18, 2026 3:45pm
The headquarters of the US Federal Trade Commission FTC in Washington DC November 18 2024

Teva moves to delist 200-plus patents from FDA registry: FTC

Dec 10, 2025 4:58pm
stack of letters mail envelopes
Favicon Fierce Biotech

Pfizer finalizes Metsera buy after contentious Novo bidding war

Nov 13, 2025 12:43pm
The headquarters of the US Federal Trade Commission FTC in Washington DC November 18 2024
Favicon Fierce Biotech

FTC tells Novo that Metsera offer may violate US merger law

Nov 5, 2025 4:26pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings